Literature DB >> 30539049

Differentially expressed serum host proteins in hepatitis B and C viral infections.

Kruti Dalal1, Priyanka Khorate1, Bhavik Dalal1, Rahul Chavan2, Shobna Bhatia3, Avinash Kale2, Akash Shukla3,4, Aruna Shankarkumar1.   

Abstract

Hepatitis B virus (HBV) and Hepatitis C virus (HCV) infection often lead to hepatocellular carcinoma (HCC), which is mostly detected in advanced stage. Hence, its early detection is of paramount importance using a biomarker having sensitivity and specificity both. The present study highlights differentially expressed host proteins in response to HBV/HCV infection at different stages. Comparative proteomic study was done by two-dimensional gel electrophoresis followed by mass spectrometry. Sera from each of chronically infected, liver cirrhosis and HCC in HBV or HCV infection along with controls were selected. Analysis of functional association between differentially expressed proteins with viral hepatitis was extensively carried out. Forty-three differentially expressed spots (≥ 1.5 fold; P < 0.05) on two-dimensional gel electrophoresis were corresponded to 28 proteins by mass spectrometry in variable liver diseases. Haptoglobin protein levels were decreased upon disease progression to HCC due to HBV infection. The other proteins expressed differentially are ceruloplasmin, serum paraoxonase 1, retinol binding protein and leucine rich alpha 2 proteins in plasma maybe associated to HBV HCC. Whereas, upregulation of C4a/C4b showed it as a reliable marker in patients with end stage liver disease related to HCV infection. ApolipoproteinA1 levels in liver diseases in both HBV and HCV infection corresponding to healthy controls may be a common marker for early diagnosis and disease monitoring. Protein interaction studies by extensive pathway analysis using bioinformatics tools such as EnrichNet application and STRING revealed significant associations with specific infections.

Entities:  

Keywords:  Hepatitis B virus; Hepatitis C virus; Hepatocellular carcinoma; Protein biomarkers

Year:  2018        PMID: 30539049      PMCID: PMC6261891          DOI: 10.1007/s13337-018-0484-y

Source DB:  PubMed          Journal:  Virusdisease        ISSN: 2347-3584


  40 in total

1.  Heparin interactions with apoA1 and SAA in inflammation-associated HDL.

Authors:  Andreas Digre; Jie Nan; Martin Frank; Jin-Ping Li
Journal:  Biochem Biophys Res Commun       Date:  2016-04-20       Impact factor: 3.575

2.  The diagnostic value of serum fucosylated fetuin A in hepatitis B virus-related liver diseases.

Authors:  Li Li; Xing Gu; Meng Fang; Jun Ji; Changhong Yi; Chunfang Gao
Journal:  Clin Chem Lab Med       Date:  2016-04       Impact factor: 3.694

3.  Serum fucosylated paraoxonase 1 as a potential glycobiomarker for clinical diagnosis of early hepatocellular carcinoma using ELISA Index.

Authors:  Shu Zhang; Kai Jiang; Qinle Zhang; Kun Guo; Yinkun Liu
Journal:  Glycoconj J       Date:  2015-02-22       Impact factor: 2.916

4.  Serum amyloid A is a novel prognostic biomarker in hepatocellular carcinoma.

Authors:  Xiao-Chun Ni; Yong Yi; Yi-Peng Fu; Hong-Wei He; Xiao-Yan Cai; Jia-Xing Wang; Jian Zhou; Jia Fan; Shuang-Jian Qiu
Journal:  Asian Pac J Cancer Prev       Date:  2014

5.  Quantitative proteomic analysis identified paraoxonase 1 as a novel serum biomarker for microvascular invasion in hepatocellular carcinoma.

Authors:  Cheng Huang; Yuwei Wang; Shengdong Liu; Guangyu Ding; Weiren Liu; Jian Zhou; Ming Kuang; Yuan Ji; Tadashi Kondo; Jia Fan
Journal:  J Proteome Res       Date:  2013-03-05       Impact factor: 4.466

6.  Proteome mapping of epidermal growth factor induced hepatocellular carcinomas identifies novel cell metabolism targets and mitogen activated protein kinase signalling events.

Authors:  Jürgen Borlak; Prashant Singh; Giuseppe Gazzana
Journal:  BMC Genomics       Date:  2015-02-25       Impact factor: 3.969

7.  Identification of Circulating Biomarker Candidates for Hepatocellular Carcinoma (HCC): An Integrated Prioritization Approach.

Authors:  Faryal Mehwish Awan; Anam Naz; Ayesha Obaid; Amjad Ali; Jamil Ahmad; Sadia Anjum; Hussnain Ahmed Janjua
Journal:  PLoS One       Date:  2015-09-28       Impact factor: 3.240

8.  Quantitative proteomic analysis in HCV-induced HCC reveals sets of proteins with potential significance for racial disparity.

Authors:  Simon T Dillon; Manoj K Bhasin; Xiaoxing Feng; David W Koh; Sayed S Daoud
Journal:  J Transl Med       Date:  2013-10-01       Impact factor: 5.531

Review 9.  Epidemiology of Hepatocellular Carcinoma in the Asia-Pacific Region.

Authors:  Ran Xu Zhu; Wai-Kay Seto; Ching-Lung Lai; Man-Fung Yuen
Journal:  Gut Liver       Date:  2016-05-23       Impact factor: 4.519

10.  The identification of key genes and pathways in hepatocellular carcinoma by bioinformatics analysis of high-throughput data.

Authors:  Chaoyang Zhang; Li Peng; Yaqin Zhang; Zhaoyang Liu; Wenling Li; Shilian Chen; Guancheng Li
Journal:  Med Oncol       Date:  2017-04-21       Impact factor: 3.064

View more
  3 in total

1.  Identification of Protein Expression Changes in Hepatocellular Carcinoma through iTRAQ.

Authors:  Yuanyuan Zhang; Xia Ying; Qian Zhao; Jinlu Ma; Dan Zhang; Chenchen He; Suxia Han
Journal:  Dis Markers       Date:  2020-01-23       Impact factor: 3.434

Review 2.  "Complimenting the Complement": Mechanistic Insights and Opportunities for Therapeutics in Hepatocellular Carcinoma.

Authors:  Astha Malik; Unmesha Thanekar; Surya Amarachintha; Reena Mourya; Shreya Nalluri; Alexander Bondoc; Pranavkumar Shivakumar
Journal:  Front Oncol       Date:  2021-02-24       Impact factor: 5.738

3.  Non-Wilson's Disease-Associated Hypoceruloplasminemia.

Authors:  Annie Gong; Samantha Leitold; Julia Uhanova; Gerald Y Minuk
Journal:  J Clin Exp Hepatol       Date:  2019-11-26
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.